Buying on the OTC market (TMDIF) or TSX Venture (CNVI) carries more technical risk and higher fees with some brokers.
The company is now a "micro-cap" stock, valued at roughly $33 million to $40 million , which makes it extremely sensitive to small pieces of news. Summary Checklist: Should You Buy? Consideration Risk Tolerance
Titan Medical was officially delisted from the Nasdaq in March 2023 because its share price stayed below $1.00 for too long. should i buy titan medical stock
The "Titan" you see today is likely the "Resulting Issuer" known as Conavi Medical Corp (CNVI.V), which focuses on image-guided technologies for minimally invasive heart procedures rather than surgical robotics. 2. Listing Status and Liquidity
If you wanted , this is no longer the right play. If you like Cardiovascular Imaging , the new Conavi entity might interest you. Market Status Buying on the OTC market (TMDIF) or TSX
Deciding whether to buy stock in requires looking at a company that has undergone massive structural changes over the last few years. As of early 2026, the short answer is that the original "Titan Medical" (TMDI) essentially no longer exists as an independent surgical robotics company following a reverse take-over and a delisting from major exchanges . 1. The Core Business Has Shifted
Make sure you aren't confusing this with other "Titan" companies, such as Titan America (TTAM - cement) or Titan Pharmaceuticals (TTNP), which are entirely different businesses. Google's Finance Data Listing Status and Liquidity If you wanted ,
If you find a ticker symbol for Titan Medical today, it is likely trading on the TSX Venture Exchange (under the new Conavi identity) or on the OTC (Over-The-Counter) markets under the ticker TMDIF . OTC stocks often have low "liquidity," meaning it can be hard to buy or sell large amounts of shares without moving the price significantly. 3. Financial Performance